Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiesse for First Impressions and Self-esteem in Malar Deficiency
NCT01225354Phase 4Completed
- Sponsor
- DeNova Research
- Start
- Aug 2010
- Primary completion
- Aug 2011
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
Phase 4, open-label trial of calcium hydroxyapatite in malar hypoplasia, sponsored by DeNova Research. Primary endpoints: Blinded Evaluations of First Impression and Self-esteem at 1 month. Started Aug 2010; status: completed.
02
Drugs
calcium hydroxyapatite
03
Conditions
malar hypoplasia
Beyond the preview
Go deeper on NCT01225354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01225354.